It was reported that this electrode was a part of a implanted subcutaneous system that had delivered a shock for ventricular tachycardia, which accelerated the arrythmia to ventricular fibrillation, which was then treated with four shocks.The patient was hospitalized and review of device data indicated the shock impedance measurements of the system were high at 130 ohms, however no values were reported to be out of range.An x-ray taken showed the electrode may have originally been implanted in a suboptimal position.Surgical intervention was later performed and the electrode was repositioned and induction testing was successful with two shocks.The electrode remains in service and there have been no additional adverse patient effects reported.
|